Ichimura K - Search Results

1

Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss.

Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, Ichimura K. Arita H, et al. Among authors: ichimura k. Acta Neuropathol. 2013 Aug;126(2):267-76. doi: 10.1007/s00401-013-1141-6. Epub 2013 Jun 14. Acta Neuropathol. 2013. PMID: 23764841

2

Amplification at 12q13-14 in human malignant gliomas is frequently accompanied by loss of heterozygosity at loci proximal and distal to the amplification site.

Reifenberger G, Reifenberger J, Ichimura K, Collins VP. Reifenberger G, et al. Among authors: ichimura k. Cancer Res. 1995 Feb 15;55(4):731-4. Cancer Res. 1995. PMID: 7850781

3

CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

Schmidt EE, Ichimura K, Reifenberger G, Collins VP. Schmidt EE, et al. Among authors: ichimura k. Cancer Res. 1994 Dec 15;54(24):6321-4. Cancer Res. 1994. PMID: 7987821

4

Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2.

Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP. Reifenberger G, et al. Among authors: ichimura k. Cancer Res. 1994 Aug 15;54(16):4299-303. Cancer Res. 1994. PMID: 8044775

5

A common region of homozygous deletion in malignant human gliomas lies between the IFN alpha/omega gene cluster and the D9S171 locus.

Ichimura K, Schmidt EE, Yamaguchi N, James CD, Collins VP. Ichimura K, et al. Cancer Res. 1994 Jun 15;54(12):3127-30. Cancer Res. 1994. PMID: 8205529

6

Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.

Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP. Reifenberger G, et al. Among authors: ichimura k. Cancer Res. 1993 Jun 15;53(12):2736-9. Cancer Res. 1993. PMID: 8504413

7

Epidermal growth factor receptor expression in oligodendroglial tumors.

Reifenberger J, Reifenberger G, Ichimura K, Schmidt EE, Wechsler W, Collins VP. Reifenberger J, et al. Among authors: ichimura k. Am J Pathol. 1996 Jul;149(1):29-35. Am J Pathol. 1996. PMID: 8686753 Free PMC article.

8

Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.

Ichimura K, Schmidt EE, Goike HM, Collins VP. Ichimura K, et al. Oncogene. 1996 Sep 5;13(5):1065-72. Oncogene. 1996. PMID: 8806696

9

Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.

Reifenberger G, Ichimura K, Reifenberger J, Elkahloun AG, Meltzer PS, Collins VP. Reifenberger G, et al. Among authors: ichimura k. Cancer Res. 1996 Nov 15;56(22):5141-5. Cancer Res. 1996. PMID: 8912848

10

Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours.

Schmidt EE, Ichimura K, Messerle KR, Goike HM, Collins VP. Schmidt EE, et al. Among authors: ichimura k. Br J Cancer. 1997;75(1):2-8. doi: 10.1038/bjc.1997.2. Br J Cancer. 1997. PMID: 9000591 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

875 results

Search Page

Filters